Policy Insights - The 2025 government work report emphasizes the dual carbon goals, aiming for carbon peak and neutrality, and promoting green transformation in economic and social development[19] - The report sets ecological and environmental work targets for 2025, focusing on pollution prevention, ecological construction, and the development of a green low-carbon economy[20] International ESG Developments - The European Commission introduced the "Clean Industrial Deal" to accelerate decarbonization and support European manufacturing, addressing climate change and industrial competitiveness[9] - A temporary agreement in the EU mandates fashion brands to pay for the collection and recycling of their products, with a target to reduce textile waste by 10% and food waste by 30% by 2030[11] Domestic ESG Initiatives - Four departments jointly released guidelines to promote voluntary disclosure of greenhouse gas emissions by enterprises, aiming to establish a disclosure system by 2027[21] - The National Financial Regulatory Administration and the People's Bank of China issued a plan to develop high-quality green finance in the banking and insurance sectors, with 24 measures outlined[24] Corporate Sustainability Trends - A Workiva survey found that 85% of executives plan to continue their climate reporting initiatives despite regulatory uncertainties, highlighting the strategic benefits of sustainability reporting[14] - The International Civil Aviation Organization launched the ICAO Finvest Hub to connect investors with sustainable aviation projects, prioritizing support for developing countries[16]

Investment Rating - The report maintains a "Positive" investment rating for the defense and military industry in China [5]. Core Insights - The global military trade market is expected to grow significantly due to ongoing geopolitical conflicts, with China's military products becoming increasingly competitive in terms of cost-effectiveness [3][7]. - China's military trade exports have shown a remarkable increase, with the export volume rising from 314 million TIV in 2000 to 2.432 billion TIV in 2023, representing a nearly sevenfold increase [42][45]. - The report highlights the potential for various military products, including drones, tanks, and missiles, to capture a larger share of the international market [3][7]. Summary by Sections Global Military Trade Demand - Global military trade demand remains high despite a slight decline in 2023, with a peak of 33.544 billion TIV in 2022, reflecting a 27.3% year-on-year growth [16][38]. - The demand side is relatively fragmented, with the top ten importers, including India and Saudi Arabia, accounting for 48% of total imports [18][19]. Geopolitical Conflicts and Military Spending - Geopolitical tensions have led to increased military spending globally, with 2023 military expenditures reaching $2.39 trillion, marking a 6.8% increase from the previous year [36][38]. - The report notes that military trade is positively correlated with military spending, indicating that rising defense budgets will likely boost military trade volumes [38][39]. China's Military Trade Landscape - China's military exports are concentrated in a few key markets, with Pakistan being the largest importer, accounting for 58% of exports from 2018 to 2023 [45][47]. - The types of military equipment exported by China include aircraft, ships, armored vehicles, and missiles, which together account for 86% of total exports [48][49]. Investment Recommendations - The report suggests focusing on specific companies within the military sector, such as Guorui Technology for radar systems, Inner Mongolia First Machinery Group for tanks, and Zhongyun Drone for unmanned aerial vehicles [7][8].

国防军工行业 行业研究 | 深度报告 国际局势不稳定下中国军贸迎来新机遇， 技术迭代引领增长新势能 国家/地区 中国 行业 国防军工行业 报告发布日期 2025 年 03 月 07 日 看好（维持） | 罗楠 | 021-63325888*4036 | | --- | --- | | 冯函 | luonan@orientsec.com.cn | | | 执业证书编号：S0860518100001 | | | 021-63325888*2900 | | | fenghan@orientsec.com.cn | | | 执业证书编号：S0860520070002 | | 鲍丙文 | baobingwen@orientsec.com.cn | | 主链新一轮景气周期可期，新质新域扩宽 | 2024-12-23 | | --- | --- | | 成长空间：——国防军工行业 2025 年度投 | | | 资策略 | | | 2024 珠海航展亮点速递 | 2024-11-14 | 有关分析师的申明，见本报告最后部分。其他重要信息披露见分析师申明之后部分，或请与您的投资代表联系。并请阅读本证券研究报告最后一页的免责申明 ...

Investment Rating - The report maintains a "Positive" outlook for the electronic industry [4] Core Insights - The Deepseek integrated machine is driving AI acceleration across various industries, with multiple manufacturers launching products that support the Deepseek model, enhancing deployment efficiency [7][8] - The integration of hardware and software in Deepseek machines significantly lowers the technical barriers for AI deployment, creating new opportunities for various sectors [13][14] - Domestic chips are becoming a foundational element for Deepseek machines, with over 80 companies adapting or launching Deepseek models based on domestic chip technology [11][12] Summary by Sections Investment Recommendations and Targets - The report suggests focusing on investment opportunities in companies related to the Deepseek integrated machine supply chain, including: 1. Chips: Haiguang Information, Longxin Zhongke, Lanke Technology, and Cambricon 2. Complete machines: Hikvision, Lenovo Group, and Dahua Technology [2][18] Industry Dynamics - The report highlights the rapid industrialization of AI integrated machines, with significant advancements in the Deepseek model's application across cloud computing, intelligent computing, and data center sectors [8] - Various manufacturers are adopting domestic chips and frameworks to enhance their integrated machine solutions, promoting a more localized AI ecosystem [9][12] Technological Advancements - Deepseek integrated machines are designed for soft and hardware optimization, allowing for dynamic resource allocation and improved performance [11][12] - The machines are equipped with pre-deployed models and industry-specific adaptations, significantly reducing the time required for AI application deployment [13][14]

拟收购控股子公司江苏奥雷部分股权，助 推防务领域光电产品进一步拓展 核心观点 事件：航天电器董事会决议使用自有资金 5693.33 万元收购中国奥雷持有的江苏奥雷 32.70%股权，本次收购完成后，公司共持有江苏奥雷 96.54%股权。 盈利预测与投资建议 ⚫ 根据 24 年业绩预告，由于公司防务产业阶段性需求放缓以及批产任务订单不饱满， 公司的营收受到一定影响，同时考虑到费用存在刚性，调整 24、25、26 年 EPS 为 0.79、1.86、2.32 元（前值为 1.78、2.10、2.60 元），参考可比公司 25 年 37 倍 PE，给予目标价 68.82 元，维持买入评级。 风险提示 军品订单下放和收入确认进度不及预期；降价幅度具有不确定性等。 公司主要财务信息 | | 2022A | 2023A | 2024E | 2025E | 2026E | | --- | --- | --- | --- | --- | --- | | 营业收入(百万元) | 6,020 | 6,210 | 5,043 | 7,375 | 8,915 | | 同比增长 (%) | 17.0% | 3.2% | -18.8% ...

Investment Rating - The report gives an "Accumulate" rating for the company for the first time, with a target price of 18.88 CNY based on a 59 times P/E ratio for 2026 [5][8]. Core Views - The company is positioned as a leading domestic chromatography manufacturer, entering a new growth cycle, with significant revenue and profit growth expected in the coming years [11][16]. - The industrial purification segment is identified as the core growth driver, with strong downstream demand and plans for new capacity to enhance market share [11][12]. Financial Forecast and Investment Recommendations - The company is projected to achieve earnings per share of 0.21 CNY, 0.27 CNY, and 0.32 CNY for 2024, 2025, and 2026 respectively, with revenues expected to grow from 3.15 billion CNY in 2024 to 4.49 billion CNY in 2026 [5][7]. - The report highlights a compound annual growth rate (CAGR) of 34% for revenue from 2019 to 2024 and an impressive 86% CAGR for net profit from 2020 to 2024 [25][11]. Company Overview - The company, established in 2002 in the USA, specializes in analytical chromatography and industrial purification chromatography fillers, with a strong R&D and production capability in both fields [11][16]. - The company has a clear ownership structure and has attracted significant strategic investors, enhancing its market position [18][19]. Product Competitiveness - The company’s core products in both industrial purification and analytical chromatography are competitive, with strong performance metrics compared to imported products [11][12]. - The industrial purification segment has rapidly gained traction since 2020, becoming the company's main business and growth engine [25][11]. Market Demand and Growth Potential - There is a robust demand for the company’s products, with a significant increase in early clinical projects and a strong pipeline of late-stage clinical and commercial projects [11][12]. - The report notes a trend towards domestic substitution in the chromatography market, driven by cost pressures and the need for stable supply chains [11][12]. Financial Performance - The company’s revenue increased from 0.74 billion CNY in 2019 to 3.15 billion CNY in 2024, with a notable increase in profitability [25][27]. - The gross margin has shown improvement, with the company achieving a leading position in the industry [35][36].

Investment Rating - The report gives an "Accumulate" rating for the company for the first time, with a target price of 18.88 CNY based on a 59 times P/E ratio for 2026 [5][8]. Core Views - The company is positioned as a leading domestic chromatography manufacturer, entering a new growth cycle with rapid revenue and profit growth, particularly in the industrial purification segment, which has become the core business [11][25]. - The company has strong competitive advantages in its core products, with both industrial purification and analytical chromatography segments showing robust performance and collaboration with key clients [11][12]. - There is significant growth potential driven by strong downstream demand and a trend towards domestic substitution in the chromatography market, especially in the context of rising cost pressures from drug price reductions [11][12]. Financial Forecast and Investment Recommendations - The company is projected to achieve earnings per share of 0.21 CNY, 0.27 CNY, and 0.32 CNY for the years 2024, 2025, and 2026 respectively, with a rapid increase in revenue expected from the industrial purification segment [5][11]. - Revenue is expected to grow from 2.13 billion CNY in 2022 to 4.49 billion CNY in 2026, reflecting a compound annual growth rate (CAGR) of 34% from 2019 to 2024 [7][25]. - The net profit attributable to the parent company is forecasted to rise from 470 million CNY in 2022 to 1.33 billion CNY in 2026, with a CAGR of 86% from 2020 to 2024 [7][25]. Company Overview - The company, established in 2002 in the United States, specializes in analytical chromatography and industrial purification chromatography fillers, and is one of the few companies with R&D and large-scale production capabilities in both fields [11][16]. - The company has a clear equity structure and has attracted significant strategic investors, enhancing its market position and operational capabilities [18][19]. Product Competitiveness - The company’s industrial purification products are primarily used in the clinical research and industrial production phases of drug development, with a comprehensive range of over 100 products covering various separation modes and application scenarios [46][50]. - The analytical chromatography segment has a stable revenue structure, primarily driven by size exclusion chromatography columns, while the industrial purification segment has shown significant growth since 2020 [32][46]. Market Demand and Growth Potential - The company has accumulated a substantial number of early-stage projects, with 106 early clinical projects and 56 late clinical and commercial projects expected to drive demand [11][12]. - The domestic chromatography and industrial purification market has a high concentration and low domestic substitution rate, indicating significant growth opportunities as the trend towards domestic products increases [11][12].

Investment Rating - The report maintains a "Buy" rating for Alibaba Group [2][6] Core Insights - Alibaba's FY3Q25 performance exceeded expectations with revenue of 280.15 billion yuan, a year-on-year increase of 7.6%, and adjusted net profit of 51.07 billion yuan, up 6.5% [4][6] - The company is entering a new growth cycle driven by AI, with significant capital expenditure planned to enhance cloud computing and AI infrastructure [4][9] - The report highlights improvements in operational efficiency and a reduction in losses across various business segments, particularly in local services and international commerce [4][6] Financial Performance Summary - **Revenue and Profitability**: FY3Q25 revenue was 2801.5 billion yuan, exceeding Bloomberg consensus of 2774 billion yuan; adjusted net profit was 510.7 billion yuan, significantly above the expected 455 billion yuan [4][6] - **Taobao Group**: Revenue reached 1360.9 billion yuan, a 5.4% year-on-year increase, with adjusted EBITA of 610.8 billion yuan, up 1.9% [4][6] - **Cloud Intelligence Group**: Revenue was 317.4 billion yuan, a 13.1% increase, with adjusted EBITA of 31.4 billion yuan, up 32.7% [4][6] - **International Digital Commerce**: Revenue grew by 32.4% to 377.6 billion yuan, driven by growth in AliExpress and Trendyol [4][6] - **Capital Expenditure**: FY3Q25 capital expenditure was 317.8 billion yuan, a 258.8% increase year-on-year, reflecting a strong commitment to AI and cloud infrastructure [4][6] Earnings Forecast and Valuation - Projected revenues for FY2025-2027 are 10046 billion yuan, 11230 billion yuan, and 12545 billion yuan respectively, with adjusted net profits of 1577 billion yuan, 1656 billion yuan, and 1863 billion yuan [6][22] - The estimated market capitalization based on segment valuation is 30703 billion yuan, corresponding to a target price of 175.10 HKD per share [6][22]

Investment Rating - The report maintains a "Buy" rating for Alibaba [2][6][22] Core Insights - Alibaba's FY3Q25 performance exceeded expectations with revenue of 2801.5 billion yuan, a year-on-year increase of 7.6%, and adjusted net profit of 510.7 billion yuan, up 6.5% [4][6] - The company is entering a new growth cycle driven by AI, with significant capital expenditure planned to enhance cloud computing and AI infrastructure [4][9][22] Financial Performance - Alibaba's revenue for FY3Q25 was 2801.5 billion yuan, surpassing Bloomberg consensus of 2774 billion yuan [4] - Adjusted net profit for FY3Q25 was 510.7 billion yuan, significantly above the expected 455 billion yuan [4] - The company's capital expenditure for FY3Q25 reached 317.8 billion yuan, a year-on-year increase of 258.8% [4][9] Business Segments - Taobao Group generated revenue of 1360.9 billion yuan in FY3Q25, a year-on-year increase of 5.4% [4] - Cloud Intelligence Group reported revenue of 317.4 billion yuan, up 13.1% year-on-year, driven by strong demand for AI-related services [4] - International Digital Commerce achieved revenue of 377.6 billion yuan, a year-on-year increase of 32.4% [4] Future Outlook - The report forecasts Alibaba's revenue for FY2025-2027 to be 10046 billion yuan, 11230 billion yuan, and 12545 billion yuan respectively [6][22] - Adjusted net profit is projected to be 1577 billion yuan, 1656 billion yuan, and 1863 billion yuan for FY2025-2027 [6][22] - The company plans to invest over 3800 billion yuan in AI and cloud computing infrastructure over the next three years [9][22]